IRIS
IANNONE, Florenzo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 21.581
AS - Asia 8.748
EU - Europa 6.476
SA - Sud America 2.361
AF - Africa 371
Continente sconosciuto - Info sul continente non disponibili 17
OC - Oceania 16
Totale 39.570
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 21.232
SG - Singapore 3.795
BR - Brasile 1.850
CN - Cina 1.847
FR - Francia 1.142
HK - Hong Kong 1.088
SE - Svezia 1.008
IT - Italia 991
RU - Federazione Russa 886
DE - Germania 755
VN - Vietnam 581
FI - Finlandia 574
GB - Regno Unito 436
IN - India 284
BD - Bangladesh 189
AR - Argentina 183
UA - Ucraina 167
CA - Canada 152
IQ - Iraq 135
ID - Indonesia 132
TR - Turchia 117
MX - Messico 114
ZA - Sudafrica 100
PK - Pakistan 86
JP - Giappone 85
CI - Costa d'Avorio 82
EC - Ecuador 76
BE - Belgio 71
SA - Arabia Saudita 68
CO - Colombia 65
ES - Italia 62
VE - Venezuela 62
PL - Polonia 55
IE - Irlanda 54
AT - Austria 52
NL - Olanda 49
PH - Filippine 45
UZ - Uzbekistan 45
MA - Marocco 42
CL - Cile 34
PY - Paraguay 34
CZ - Repubblica Ceca 28
LT - Lituania 28
TN - Tunisia 26
IR - Iran 24
KE - Kenya 24
JO - Giordania 21
MY - Malesia 21
PE - Perù 21
EG - Egitto 20
ET - Etiopia 20
JM - Giamaica 20
BO - Bolivia 17
NP - Nepal 16
EU - Europa 15
OM - Oman 15
AZ - Azerbaigian 14
CH - Svizzera 14
KZ - Kazakistan 14
DZ - Algeria 13
TH - Thailandia 13
AU - Australia 12
PA - Panama 12
UY - Uruguay 12
AM - Armenia 11
AE - Emirati Arabi Uniti 10
LB - Libano 10
NI - Nicaragua 10
PS - Palestinian Territory 10
RS - Serbia 10
DK - Danimarca 9
DO - Repubblica Dominicana 9
IL - Israele 9
AL - Albania 8
BG - Bulgaria 8
BH - Bahrain 8
CR - Costa Rica 8
KG - Kirghizistan 8
SN - Senegal 8
HN - Honduras 7
HR - Croazia 7
PT - Portogallo 7
QA - Qatar 7
AO - Angola 6
KR - Corea 6
MD - Moldavia 6
RO - Romania 6
SI - Slovenia 6
BB - Barbados 5
BY - Bielorussia 5
GF - Guiana Francese 5
GR - Grecia 5
HU - Ungheria 5
SY - Repubblica araba siriana 5
TW - Taiwan 5
EE - Estonia 4
MM - Myanmar 4
MU - Mauritius 4
NO - Norvegia 4
GA - Gabon 3
Totale 39.493
Salva come PNG Salva come JPEG
Città #
Fairfield 2.590
Ashburn 2.244
Singapore 2.058
Woodbridge 1.845
Houston 1.411
Chandler 1.364
San Jose 1.103
Seattle 1.079
Hong Kong 1.078
Cambridge 936
Ann Arbor 922
Wilmington 816
Nyköping 800
Beijing 586
Jacksonville 431
Dallas 397
Lauterbourg 384
Lawrence 323
Roxbury 311
Helsinki 301
New York 292
Munich 282
Los Angeles 266
Nanjing 256
Bari 230
Des Moines 203
São Paulo 179
Princeton 175
Ho Chi Minh City 174
Inglewood 172
Council Bluffs 150
Santa Clara 140
Hanoi 122
Falkenstein 120
San Diego 115
Moscow 114
Buffalo 112
London 112
Brooklyn 107
Boardman 91
Chicago 82
Abidjan 81
Dearborn 80
Turku 79
Paris 75
Shenyang 75
Jakarta 73
Brussels 71
Tokyo 67
The Dalles 62
Frankfurt am Main 60
Hebei 59
Rio de Janeiro 58
Columbus 56
Baghdad 54
Dublin 53
Dong Ket 52
Jiaxing 52
Nanchang 51
Johannesburg 50
Montreal 49
Warsaw 47
Belo Horizonte 44
Denver 44
Toronto 44
Boston 43
Milan 43
Dhaka 41
Orem 41
Atlanta 40
Poplar 40
San Francisco 40
Tianjin 39
Nuremberg 38
Tashkent 38
Mexico City 37
Changsha 36
Chennai 36
Brasília 35
Lahore 34
Stockholm 34
Manchester 32
Phoenix 31
Redwood City 31
Guangzhou 29
Pune 29
Shanghai 27
Curitiba 26
Vienna 26
Campinas 25
Rome 25
Ankara 24
Mumbai 24
Riyadh 24
Amsterdam 23
Guayaquil 23
Quito 23
Da Nang 22
Haiphong 22
Istanbul 22
Totale 27.012
Salva come PNG Salva come JPEG
Nome #
A rare association of anti-alanine-transfer RNA synthetase (anti-PL12) syndrome and sporadic inclusion body myositis 226
Survival and prognostic factors from a multicentre large cohort of unselected Italian systemic sclerosis patients 222
Serum Jo-1 Autoantibody and Isolated Arthritis in the Antisynthetase Syndrome: Review of the Literature and Report of the Experience of AENEAS Collaborative Group 209
Sarcopenia in Patients with Rheumatic Diseases: Prevalence and Associated Risk Factors 201
Safety of Long-Term Biologic Therapy in Rheumatologic Patients With a Previously Resolved Hepatitis B Viral Infection 200
No changes in N-terminal pro-brain natriuretic peptide in a longitudinal cohort of patients with systemic sclerosis-associated pulmonary arterial hypertension on therapy with bosentan 190
Autophagy markers LC3 and p62 accumulate in immune‐mediated necrotizing myopathy 189
AB0836 Drug retention rate of the first tnf inhibitor in radiographic and non radiographic axial spondyloarthritis: data from a multicenter study 187
Correlation between serum amyloid-A and serum levels of proinflammatory cytokines in patients with Behçet's disease 185
AB0065 Possible Interplay Between Serum Amyloid-A and Pro-Inflammatory Cytokines Into the Pathogenesis of Behçet's Disease 183
A Case of Osteonecrosis of the Jaw in a Patient with Crohn's Disease Treated with Infliximab 180
A Bayesian mixed treatment comparison of efficacy of biologics and small molecules in early rheumatoid arthritis 179
Basic characteristics of adults with periodic fever, aphthous stomatitis, pharyngitis, and adenopathy syndrome in comparison with the typical pediatric expression of disease 178
AB0452 Changes in Lipoproteins Associated with Tocilizumab Treatment Do not Influence the Atherogenic Index of Plasma of Rheumatoid Arthritis Patients: Table 1 175
Adalimumab Accounts for Long-Term Control of Noninfectious Uveitis Also in the Absence of Concomitant DMARD Treatment: A Multicenter Retrospective Study 174
AB0618 A unique ultrasound pattern of adipose tissue in systemic sclerosis patients: a comparison with rheumatoid arthritis patients and healthy controls. two sides of adipose tissue involvement in systemic chronic inflammatory diseases 172
A false occult hepatitis B virus infection developed in a patient with psoriatic arthritis under infliximab and methotrexate therapy 169
Mucocutaneous Involvement in Behçet's Disease: How Systemic Treatment Has Changed in the Last Decades and Future Perspectives 167
Evaluation of differences in carotid intima-media thickness in patients affected by systemic rheumatic diseases 167
Retinal vessels thrombosis as onset manifestation of systemic sclerosis: 3 clinical cases 165
Efficacy and safety profile of anti-interleukin-1 treatment in Behçet’s disease: a multicenter retrospective study 165
Obesity reduces the drug survival of second line biological drugs following a first TNF-α inhibitor in rheumatoid arthritis patients 165
AB0041 Serum Amyloid A Stimulates The Induction of Inflammatory Mediators in Monocytes from Behçet's Disease Patients: A Proof of Concept Study 164
Possible interplay between interleukin-15 and interleukin-17 into the pathogenesis of idiopathic inflammatory myopathies 163
Nailfold capillaroscopy characteristics of antisynthetase syndrome and possible clinical associations: Results of a multicenter international study 162
Clinical, histologic and prognostic features of clinically amyopathic dermatomyositis 161
Two-year survival rates of anti-TNF-α therapy in psoriatic arthritis (PsA) patients with either polyarticular or oligoarticular PsA 161
Interleukin-1 as a common denominator from autoinflammatory to autoimmune disorders: Premises, perils, and perspectives 161
Efficacy and safety of rituximab with and without methotrexate in the treatment of rheumatoid arthritis patients: Results from the GISEA register 160
Digital ulcers predict a worse disease course in patients with systemic sclerosis 159
Clinical spectrum time course in anti jo-1 positive antisynthetase syndrome: Results from an international retrospective multicenter study 159
Phenotypes Determined by Cluster Analysis and Their Survival in the Prospective European Scleroderma Trials and Research Cohort of Patients With Systemic Sclerosis 158
Unveiling the Efficacy, Safety, and Tolerability of Anti-Interleukin-1 Treatment in Monogenic and Multifactorial Autoinflammatory Diseases 156
Refractory knee giant cell tumor of the synovial membrane treated with intra-articular injection of Infliximab: A case series and review of the literature 155
AB0369 Adult-onset still’s disease treatment predictors at 1-year follow-up in a single rheumatologic centre experience 154
SAT0216 Chest Ultrasound Signs of Interstitial Lung Disease in Systemic Sclerosis Patients: A Comparison between High Resolution Chest Computed Tomography Findings 154
Golimumab in real-life settings: 2 Years drug survival and predictors of clinical outcomes in rheumatoid arthritis, spondyloarthritis, and psoriatic arthritis 152
Body mass does not affect the remission of psoriatic arthritis patients on anti-TNF-α therapy 152
Lipids and atherogenic indices fluctuation in rheumatoid arthritis patients on long-term tocilizumab treatment 152
Different switching rate of anti-TNF-α drugs in monotherapy and in combination with methotrexate in a cohort of rheumatoid arthritis patients in the real life 150
Autoimmunity and autoinflammation as the yin and yang of idiopathic recurrent acute pericarditis 150
Lipid Profile of Rheumatoid Arthritis Patients Treated with Anti-Tumor Necrosis Factor-Alpha Drugs Changes According to Disease Activity and Predicts Clinical Response 149
A comprehensive comparison between pediatric and adult patients with periodic fever, aphthous stomatitis, pharyngitis, and cervical adenopathy (PFAPA) syndrome 148
Orofacial Manifestations and Temporomandibular Disorders of Sjogren Syndrome: An Observational Study 148
A gender gap in primary and secondary heart dysfunctions in systemic sclerosis: A EUSTAR prospective study 147
Leucocytoclastic vasculitis as onset symptom of ulcerative colitis 146
Effectiveness and tuberculosis-related safety profile of interleukin-1 blocking agents in the management of Behçet's disease 146
Comparative efficacy between adalimumab and infliximab in the treatment of non-infectious intermediate uveitis, posterior uveitis, and panuveitis: a retrospective observational study of 107 patients 146
Effects and safety of rituximab in systemic sclerosis: An analysis from the European Scleroderma Trial and Research (EUSTAR) group 146
AN UNWELCOME HOST IN THE PATHOGENESIS OF ARTHRITIDES 145
Interleukin (IL)-1 inhibition with anakinra and canakinumab in Behçet's disease-related uveitis: a multicenter retrospective observational study 145
Anti-SAE dermatomyositis: clinical and histologic characteristics from a monocentric Italian cohort 144
ANTI-TNFA THERAPY IN PSORIATIC ARTHRITIS: DIFFERENT RATE OF REMISSION IN POLYARTICULAR AND OLIGOARTICULAR SUBSETS 144
Risk of invasive melanoma in patients with rheumatoid arthritis treated with biologics: Results from a collaborative project of 11 European biologic registers 143
Paradoxical mucocutaneous flare in a case of Behçet’s disease treated with tocilizumab 143
THU0153 The effect of 5-years b-dmards treatment on different 10-years cardiovascular risk scores applied in rheumatoid arthritispatients 142
Cumulative retention rate of adalimumab in patients with Behçet's disease-related uveitis: a four-year follow-up study 141
Update on laser-evoked potential findings in fibromyalgia patients in light of clinical and skin biopsy features 141
Auditory involvement in Behcet’s disease: relationship with demographic, clinical, and therapeutic characteristics 140
Chondrocytes treated with different shock wave devices 137
SAT0212 Pericardial Effusion Related To Systemic Sclerosis: A Possible Contribution of The Serum Levels of Adipokines and Interleukines 137
Serum amyloid-A in Behçet's disease 136
LIPID PROFILE OF RHEUMATOID ARTHRITIS PATIENTS TREATED WITH ANTI-TNF-ALPHA DRUGS CHANGES ACCORDING TO DISEASE ACTIVITY RESPONSE 136
PFAPA syndrome and Behçet’s disease: a comparison of two medical entities based on the clinical interviews performed by three different specialists 135
ASSOCIATION OF SYSTEMIC SCLEROSIS AND PSORIATIC ARTHRITIS: A CASE REPORT 134
Analysis of subchondral cortical plate and trabecular bone in osteoarthritis experimentally induced in goat tibia. Preliminary results 134
Proinflammatory cytokines and antiskin autoantibodies in patients with inherited epidermolysis bullosa 134
Ten-Year Retention Rate of Infliximab in Patients with Behçet's Disease-Related Uveitis 134
FRI0110 Methotrexate monotherapy in real life: a drug survival analysis. comparison between very early arthritis and early arthritis cohorts 134
Tumor necrosis factor receptor-associated periodic syndrome managed with the couple canakinumab-alendronate 133
The profiling of axial spondyloarthritis patient candidate to a biologic therapy: Consensus from a Delphi-panel of Italian experts 133
Joint and tendon involvement predict disease progression in systemic sclerosis: A EUSTAR prospective study 133
Peripheral and central nervous system correlates in fibromyalgia 132
Longterm clinical outcomes in 420 patients with psoriatic arthritis taking anti-tumor necrosis factor drugs in real-world settings 131
Untangling the web of systemic autoinflammatory diseases 131
Explainable artificial intelligence for microbiome data analysis in colorectal cancer biomarker identification 129
Improvement of renal function and disappearance of hepatitis B virus DNA in a patient with rheumatoid arthritis and renal amyloidosis following treatment with infliximab 129
Safety of etanercept and methotrexate in patients with rheumatoid arthritis and hepatitis C virus infection: A multicenter randomized clinical trial 129
Management of Small Vessel Vasculitides 128
High rate of disease remission in moderate rheumatoid arthritis on etanercept therapy: Data from GISEA, the Italian biologics register 127
Key facts and hot spots on tumor necrosis factor receptor-associated periodic syndrome 127
Evaluation of Serum Levels of Adipokines and Interleukines in Pericardial Effusion Related to Systemic Sclerosis 127
Generation of a core set of items to develop classification criteria for Scleroderma renal crisis using consensus methodology 126
Early-onset sarcoidosis caused by a rare CARD15/NOD2 de novo mutation and responsive to infliximab: a case report with long-term follow-up and review of the literature 126
Certolizumab Pegol treatment in Behcet's disease with different organ involvement: A multicenter retrospective observational study 125
Early Lupus Project: one-year follow-up of an Italian cohort of patients with systemic lupus erythematosus of recent onset 125
Perivascular and endomysial macrophages expressing VEGF and CXCL12 promote angiogenesis in anti-HMGCR immune-mediated necrotizing myopathy 125
The impact of patient heterogeneity and socioeconomic factors on abatacept retention in rheumatoid arthritis across nine European countries 124
OP0129 Drug survival on anti-tnf-alpha in psoriatic arthritis patients with axial involvement and analysis of predictors 124
A convolutional neural network with transfer learning for automatic discrimination between low and high-grade synovitis: a pilot study 123
Critical regulation of Th17 cell differentiation by serum amyloid-A signalling in Behcet's disease 122
Obesity and Inflammation – Targets for OA Therapy 122
Characteristics of joint involvement and relationships with systemic inflammation in systemic sclerosis: Results from the EULAR Scleroderma Trial and Research Group (EUSTAR) database 122
Improvement of Refractory Dysphagia in Patients with Idiopathic Inflammatory Myopathies Receveing Immunoglobulin Intravenous Therapy 122
Diagnosis of latent tuberculosis and prevention of reactivation in rheumatic patients receiving biologic therapy: International recommendations 120
Efficacy and safety of adalimumab in Behçet's disease-related uveitis: a multicenter retrospective observational study. 120
Drug survival on TNF inhibitors: 2003-2004 data from Italian National Register (GISEA Register) 119
Early clinical response predicts low disease activity at one year in rheumatoid arthritis patients on treatment with certolizumab in real-life settings. An appraisal of the Italian registry GISEA 119
Guidance for the management of patients with latent tuberculosis infection requiring biologic therapy in rheumatology and dermatology clinical practice 119
Comparative effectiveness of tocilizumab versus TNF inhibitors as monotherapy or in combination with conventional synthetic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis after the use of at least one biologic disease-modifying antirheumatic drug: analyses from the pan-European TOCERRA register collaboration 119
Totale 14.877
Salva come PNG Salva come JPEG
Categoria #
all - tutte 174.335
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 174.335
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021793 0 0 0 0 0 0 0 0 0 367 212 214
2021/20222.494 191 220 41 125 109 185 163 146 153 171 344 646
2022/20233.717 575 439 289 301 364 495 78 433 545 28 108 62
2023/20241.250 105 260 58 98 105 267 38 60 15 47 32 165
2024/20256.640 145 91 482 157 139 616 635 774 335 405 1.000 1.861
2025/202613.101 1.967 622 910 1.691 1.861 931 1.697 529 1.463 1.430 0 0
Totale 41.229